Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

about

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

Item

http://www.wikidata.org/entity/Q52626866

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@en

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@nl

type

Item

label

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@en

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@nl

prefLabel

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@en

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@nl

P1476

Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.

@en

P2093

Dean Pavlick

http://www.w3.org/2001/XMLSchema#string

Gregory M Riedlinger

http://www.w3.org/2001/XMLSchema#string

Hua Zhong

http://www.w3.org/2001/XMLSchema#string

Jatinder Dhami

http://www.w3.org/2001/XMLSchema#string

Judith K Amorosa

http://www.w3.org/2001/XMLSchema#string

Julia A Elvin

http://www.w3.org/2001/XMLSchema#string

Kim M Hirshfield

http://www.w3.org/2001/XMLSchema#string

Lorna Rodriguez-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Mira Hellmann

http://www.w3.org/2001/XMLSchema#string

Shridar Ganesan

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

Regulation of mTORC1 by PI3K signaling

Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.

Identification of targetable FGFR gene fusions in diverse cancers.

Response and acquired resistance to everolimus in anaplastic thyroid cancer

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

P31

scholarly article

P356

10.1101/MCS.A002089

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29588307

http://www.w3.org/2001/XMLSchema#string

P932

5880253

http://www.w3.org/2001/XMLSchema#string